RIGL - RIGEL PHARMACEUTICALS INC
28.87
-0.650 -2.251%
Share volume: 354,349
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$29.52
-0.65
-0.02%
Summary score
40%
Profitability
25%
Dept financing
31%
Liquidity
50%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-27.96%
Return on assets
-20.61%
Return on sales
0%
Return on invested capital
112.85%
Total debt ratio
22.39%
Debt ratio change over timeo
0%
Current Ratio
4.65%
Quick Ratio
0%
Cash Position Ratio
1.63%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.37%
Return on assets
-20.97%
Return on sales
0%
Return on invested capital
110.54%
Total debt ratio
21.58%
Debt ratio change over timeo
0%
Current Ratio
4.76%
Quick Ratio
0%
Cash Position Ratio
1.72%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-31.44%
Return on assets
-25.06%
Return on sales
0%
Return on invested capital
132.61%
Total debt ratio
21.17%
Debt ratio change over time
0%
Current Ratio
4.64%
Quick Ratio
0%
Cash Position Ratio
1.72%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RIGL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -27.96% | 4.12% | 5.6% | 28.84% |
| Return on assets | -20.61% | 2.87% | 3.58% | 3.88% |
| Return on sales | 0% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | 112.85% | 4.34% | 6.5% | 4.27% |
| Profitability | 25% | 36% | 48% | 76% |
| Total debt ratio | 22.39% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 17% | 14% | 25% |
| Current Ratio | 4.76% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 1.72% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 27% | 46% | 39% |
| Short-term ratios | RIGL | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -26.37% | 3.9% | 5.53% | 29.97% |
| Return on assets | -20.97% | 2.93% | 3.51% | 3.83% |
| Return on sales | 0% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | 110.54% | 4.21% | 6.14% | 4.25% |
| Profitability | 25% | 37% | 48% | 76% |
| Total debt ratio | 21.58% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 18% | 14% | 25% |
| Current Ratio | 4.76% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 0% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 1.72% | 0.31% | 0.62% | 0.55% |
| Liquididy | 50% | 27% | 44% | 39% |